Payer costs of patients diagnosed with epilepsy

Payer costs of patients diagnosed with epilepsy

Toon andere (1) versies

Bibliografische gegevens
Hoofdauteur:	Griffiths, R
Formaat:	Journal article
Gepubliceerd in:	1999

Gelijkaardige items

Payer costs of patients diagnosed with epilepsy.
door: Griffiths, R, et al.
Gepubliceerd in: (1999)

Factors influencing third party payer costs for allogeneic BMT.
door: Griffiths, R, et al.
Gepubliceerd in: (1993)

Pourquoi Payer ?
door: Mary Ann Bates, et al.
Gepubliceerd in: (2012-01-01)

Single-Payer Health Care Reform: Cost Considerations in Maine
door: Daniel Bryant
Gepubliceerd in: (2024-09-01)

Unreliable VAT payer
door: Vladimír Balcar
Gepubliceerd in: (2021-06-01)

Impact of payer rejections and out-of-pocket costs on patient access to bempedoic acid therapy
door: Jimin Hwang, et al.
Gepubliceerd in: (2025-03-01)

Patient and Payer Preferences for Additional Value Criteria
door: Ivett Jakab, et al.
Gepubliceerd in: (2021-06-01)

The Payer and Patient Cost Burden of Open Breast Conserving Procedures Following Percutaneous Breast Biopsy
door: Chloe C Kimball, et al.
Gepubliceerd in: (2018-06-01)

Cost of hospitalization for firearm injuries by firearm type, intent, and payer in the United States
door: Corinne Peek-Asa, et al.
Gepubliceerd in: (2017-07-01)

Costs of Hip Fractures in Postmenopausal Women in Portugal: A Study from the Payer’s Perspective
door: Anabela Barcelos, et al.
Gepubliceerd in: (2023-12-01)

Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective
door: Brian Murray, et al.
Gepubliceerd in: (2023-01-01)

Payer plus pour étudier mieux ?
door: Sandrine Garcia
Gepubliceerd in: (2008-11-01)

THE TAX ADVANTAGES OF INCOME TAX PAYERS
door: SUCIU GHEORGHE
Gepubliceerd in: (2015-04-01)

An integrated valuation model for payer and investor
door: Mark Nuijten, et al.
Gepubliceerd in: (2022-12-01)

Are payers treating orphan drugs differently?
door: Joshua P. Cohen, et al.
Gepubliceerd in: (2014-01-01)

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective
door: Stuart Silverman, et al.
Gepubliceerd in: (2015-01-01)

Incremental cost of premature birth – a public health care payer perspective from Hungary
door: Gábor Kovács, et al.
Gepubliceerd in: (2023-06-01)

Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives
door: Mabel Aoun, et al.
Gepubliceerd in: (2022-05-01)

The impact of price transparency and competition on hospital costs: a research on all-payer claims databases
door: Ahreum Han, et al.
Gepubliceerd in: (2022-11-01)

Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population
door: Bartels-Peculis L, et al.
Gepubliceerd in: (2020-06-01)

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
door: Irfan Cicin, et al.
Gepubliceerd in: (2021-06-01)

Penal fiscal liability of bailiff as the VAT payer
door: Fabian Nalikowski
Gepubliceerd in: (2016-03-01)

An Analysis of Psychosis Readmissions: Payer Class Differences
door: Haylei Lorca
Gepubliceerd in: (2012-01-01)

Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective
door: George Joseph, et al.
Gepubliceerd in: (2021-09-01)

Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses.
door: Christopher Cai, et al.
Gepubliceerd in: (2020-01-01)

COVID-19-associated costs and mortality in Germany: an incidence-based analysis from a payer’s perspective
door: Florian Brandt, et al.
Gepubliceerd in: (2024-03-01)

Analysis of hospital and payer costs of care: aggressive warming versus routine warming in abdominal major surgery
door: Shujia Song, et al.
Gepubliceerd in: (2023-11-01)

Correction: Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives
door: Mabel Aoun, et al.
Gepubliceerd in: (2022-06-01)

Cost-Effectiveness Of The SQ® Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
door: Vogelberg C, et al.
Gepubliceerd in: (2019-11-01)

The perspective of tax payers to electronic tax filing system /
door: 293078 See, Wern Sian, et al.
Gepubliceerd in: (2007)

Challenges of Using NIK as a Tax Payer Identity
door: Titin Fachriah Nur, et al.
Gepubliceerd in: (2022-12-01)

Prescription drug spending by payer: Implications for managed care
door: Yousef Chavehpour, et al.
Gepubliceerd in: (2024-03-01)

COMPETITION AMONG PAYERS IN HEALTH CARE. THEORETICAL APPROACH
door: Anna Hnatyszyn-Dzikowska
Gepubliceerd in: (2013-06-01)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
door: Epstein RS
Gepubliceerd in: (2021-09-01)

Role of EEG in Diagnosing Abdominal Epilepsy Patients
door: Swati Sunil Jagtap, et al.
Gepubliceerd in: (2018-12-01)

Costs of Assisted Home Dialysis: A Single-Payer Canadian Model From ManitobaPlain-Language Summary
door: Ryan J. Bamforth, et al.
Gepubliceerd in: (2021-11-01)

The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective
door: Katia Iskandar, et al.
Gepubliceerd in: (2021-05-01)

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
door: Baker CL, et al.
Gepubliceerd in: (2018-07-01)

Implementing a Hybrid Model of Therapy is a Win for Therapists, Patients and Payers
door: Ben Galin
Gepubliceerd in: (2024-01-01)

Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
door: Edmonds, T, et al.
Gepubliceerd in: (2024)